ICCM Forex-Nachrichten
IceCure Medical Says FDA Clears Next-Gen XSense Cryoablation System With CryoProbes
IceCure Medical Ltd. (ICCM) announced Monday it has received marketing authorization from the U.S. Food and Drug Administration (FDA) for its next-generation single probe cryoablation system, the XSense Cryoablation System with CryoProbes.
RTTNews
|
vor 831 Tagen
